Where does SimBioSys's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across SimBioSys's 2 recorded funding rounds.

Premier Alternatives

SimBioSys

Chicago, IL · Founded 2017 · Privately Held (backing)

Developer of a medical platform intended to deploy computational oncology to transform decision-making and patient experience in cancer care. SimBioSys is based in Chicago, IL and was founded in 2017. Its last reported valuation was $39 million in Jul 2021. It has raised $21.1 million across 2 recorded rounds; the latest was a $5.2 million early-stage round in Dec 2024.

Last reported valuation

$39.0M

Oct 2026

Priced at

—

Total raised

$21.1M

Last round

Early Stage VC

Dec 2024

Cap table — not yet on record

SimBioSys's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of SimBioSys with a free account

·The complete investor list: 11 names
·Watch SimBioSys: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about SimBioSys

Where does SimBioSys's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across SimBioSys's 2 recorded funding rounds.